Pharmaceutical giants across the world have witnessed higher sales in drugs related to respiratory, anti-diabetic, cardiac therapies due to coronavirus as compared to other drugs. This is because ...

Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to ...

This marks the first time an anti-diabetic medication has been approved for managing this serious sleep disorder. OSA is a condition characterized by intermittent pauses in breathing during sleep ...

India’s drug price regulator has capped retail prices for 53 drug formulations used in treating various diseases and ...

Sotagliflozin, a newly FDA-approved medication for treating type 2 diabetes and kidney disease with added cardiovascular risks, has been shown to greatly lower the risk of heart attacks and ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

and drug stability of current therapies remain limited. Plant-based treatments, which have long been used in traditional medicine, are now being investigated for anti-diabetic properties.